| Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study.Blood Adv | PMID 34477816PMC8525228 | 2021-Sep-14 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.JAMA | PMID 34519801PMC8441593 | 2021-Sep-14 | 1.00 | 命中用户提供的消化道肿瘤阳性参考集。 | 待处理 |
| Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.JAMA | PMID 34519802PMC8441591 | 2021-Sep-14 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.J Clin Oncol | PMID 34133211PMC8425847 | 2021-Sep-10 | 1.00 | 命中用户提供的消化道肿瘤阳性参考集。 | 待处理 |
| Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis.J Clin Oncol | PMID 34138638无 PMCID | 2021-Sep-10 | 0.96 | 明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。 | 待处理 |
| Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial.J Clin Oncol | PMID 34197181PMC8425842 | 2021-Sep-10 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection.Sci Rep | PMID 34504196PMC8429542 | 2021-Sep-09 | 0.95 | Eligible study type (oncology, human, randomized, Phase 3, drug intervention, original results) but excluded because it lacks a primary/key secondary time-to-event efficacy endpoint. | 待处理 |
| A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.Vaccine | PMID 34315611无 PMCID | 2021-Sep-07 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial.J Natl Cancer Inst | PMID 33606023无 PMCID | 2021-Sep-04 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT.Arthritis Res Ther | PMID 34481517PMC8418044 | 2021-Sep-04 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Clinical and Histological Characterization of Toxic Keratopathy From Depatuxizumab Mafodotin (ABT-414), an Antibody-Drug Conjugate.Cornea | PMID 33201054无 PMCID | 2021-Sep-01 | 0.99 | 记录类型属于综述、Meta 分析、社论、评论、病例或指南。 | 待处理 |
| Management of fatigue with physical activity and behavioural change support in vasculitis: a feasibility study.Rheumatology (Oxford) | PMID 33369680PMC8410006 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitors.Rheumatology (Oxford) | PMID 33479721PMC8410000 | 2021-Sep-01 | 0.96 | 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 | 待处理 |
| EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study: A Randomized Clinical Trial.Retina | PMID 33782365PMC8384251 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.Neuro Oncol | PMID 33914057PMC8408862 | 2021-Sep-01 | 0.90 | Eligible: This is a primary report of a randomized Phase III oncology trial (EORTC CATNON) in humans with a drug-containing intervention (temozolomide) and a primary time-to-event efficacy endpoint (overall survival). | 待处理 |
| Viscoelastic testing to assess the effects of rapid fibrinogen concentrate administration after cardiopulmonary bypass: insights from the REPLACE study.Blood Coagul Fibrinolysis | PMID 33973891无 PMCID | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial.Am J Hematol | PMID 34050972无 PMCID | 2021-Sep-01 | 0.85 | The study is a Phase III randomized trial of a drug combination in oncology, but the reported results are focused exclusively on patient-reported quality of life outcomes (EORTC QLQ-C30, MDASI). No time-to-event efficacy endpoint (like OS or PFS) is reported or analyzed in this specific abstract. Therefore, it does not meet the primary criterion for inclusion as a KM/HR study. | 待处理 |
| Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.Am J Hematol | PMID 34062004PMC8457116 | 2021-Sep-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.Clin Cancer Res | PMID 34108184PMC9401497 | 2021-Sep-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases.Clin Cancer Res | PMID 34112708无 PMCID | 2021-Sep-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials.Eur J Pharm Sci | PMID 34116176无 PMCID | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines.Pediatr Infect Dis J | PMID 34117198PMC8357045 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Early Prehospital Tranexamic Acid Following Injury Is Associated With a 30-day Survival Benefit: A Secondary Analysis of a Randomized Clinical Trial.Ann Surg | PMID 34132695PMC8480233 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.Am J Hematol | PMID 34161616PMC8457136 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.JAMA Psychiatry | PMID 34190962PMC8246337 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.JAMA Oncol | PMID 34264305PMC8283666 | 2021-Sep-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.JAMA Oncol | PMID 34264316PMC8283667 | 2021-Sep-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA Oncol | PMID 34292305PMC8299367 | 2021-Sep-01 | 0.96 | 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 | 待处理 |
| Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies.J Neuroophthalmol | PMID 34310464PMC8366757 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.JAMA Dermatol | PMID 34347860PMC8340015 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.J Acquir Immune Defic Syndr | PMID 34397746PMC8357046 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study.J Neuroophthalmol | PMID 34415265PMC8366761 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.Am J Gastroenterol | PMID 34465695无 PMCID | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.JAMA Netw Open | PMID 34477854PMC8417758 | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data.J Drugs Dermatol | PMID 34491022无 PMCID | 2021-Sep-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Low-dose fractionated radiation with induction docetaxel and cisplatin followed by concurrent cisplatin and radiation therapy in locally advanced nasopharyngeal cancer: A randomized phase II-III trial.Hematol Oncol Stem Cell Ther | PMID 32504593无 PMCID | 2021-Sep | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.Dig Liver Dis | PMID 33060043无 PMCID | 2021-Sep | 0.95 | The study is a Phase III randomized trial of a drug intervention in humans, but it investigates a non-oncology condition (paediatric NAFLD) and does not report a time-to-event efficacy endpoint (OS, PFS, DFS, etc.) as a primary or key secondary outcome. The endpoints are inflammatory and oxidative stress biomarkers, not survival or progression metrics. | 待处理 |
| EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.Gut | PMID 33199443PMC8355876 | 2021-Sep | 0.45 | The study meets most inclusion criteria: it is a Phase III, randomized, human oncology trial with a drug-containing intervention (panitumumab + chemotherapy). However, the abstract does not provide explicit reporting of a primary or key secondary time-to-event efficacy endpoint such as OS, PFS, DFS, EFS, RFS, or TTP, nor does it mention Kaplan-Meier analysis or hazard ratios. The deterministic review correctly flagged a lack of time-to-event signal, so eligibility cannot be confirmed without verifying the full-text for the presence of these results. | 待处理 |
| Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.Mult Scler | PMID 33205682PMC8414818 | 2021-Sep | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.Strahlenther Onkol | PMID 33320286PMC8397631 | 2021-Sep | 0.45 | The record describes a secondary analysis of guideline impact and adoption within a Phase III randomized controlled trial (HYPOSIB). While it is a definitive oncology trial, the reported outcomes are related to treatment adoption and patient characteristics, not the survival, progression, recurrence, death, or other efficacy outcomes required for inclusion. | 待处理 |
| Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder.Bipolar Disord | PMID 33368969无 PMCID | 2021-Sep | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea.Sleep Breath | PMID 33394323PMC8376693 | 2021-Sep | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection.Clin Lung Cancer | PMID 33736940无 PMCID | 2021-Sep | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.Clin Transl Oncol | PMID 33738704无 PMCID | 2021-Sep | 0.90 | The record is a Phase II randomized trial in oncology with a drug intervention and original results. However, it is excluded because it does not meet the key eligibility criteria: it is not a Phase III or definitive Phase II/III trial, and its primary and secondary endpoints (incidence and duration of oral mucositis) are not a primary/key secondary time-to-event efficacy endpoint such as OS, PFS, DFS, EFS, RFS, or TTP, nor do the results include a Kaplan-Meier or HR analysis for such an endpoint. | 待处理 |
| Efficacy and Safety of Diclofenac-Hyaluronate Conjugate (Diclofenac Etalhyaluronate) for Knee Osteoarthritis: A Randomized Phase III Trial in Japan.Arthritis Rheumatol | PMID 33749997PMC8456865 | 2021-Sep | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis.Am J Ophthalmol | PMID 33773984无 PMCID | 2021-Sep | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial.Clin Transl Oncol | PMID 33792839无 PMCID | 2021-Sep | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.Breast Cancer | PMID 33797023PMC8354907 | 2021-Sep | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 待处理 |
| Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes.J Neurol Neurosurg Psychiatry | PMID 33879535PMC8372398 | 2021-Sep | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically Integrated, Cluster, Randomized Trial.J Urol | PMID 33904798PMC8441991 | 2021-Sep | 0.93 | 干预为非药物单独策略,未满足药物干预要求。 | 待处理 |